HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

C Dixon Selected Research

Multiple Sclerosis

4/2009Engineering a stable and selective peptide blocker of the Kv1.3 channel in T lymphocytes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


C Dixon Research Topics

Disease

1Treatment-Resistant Schizophrenia
02/2024
1Psychotic Disorders (Schizoaffective Disorder)
02/2024
1Keratitis
11/2023
1Nausea
01/2023
1Hypotension (Low Blood Pressure)
01/2023
1Vomiting
01/2023
1Tachycardia (Tachyarrhythmias)
01/2023
1Rheumatoid Arthritis
04/2009
1Type 1 Diabetes Mellitus (Autoimmune Diabetes)
04/2009
1Hypersensitivity (Allergy)
04/2009
1Multiple Sclerosis
04/2009
1Infections
03/2004
1Hidradenitis
04/2001
1Acne Vulgaris
04/2001
1Adenoma (Adenomas)
04/2001
1Hyperplasia
04/2001
1Nevus (Nevi)
04/2001

Drug/Important Bio-Agent (IBA)

1Clozapine (Clozaril)FDA LinkGeneric
02/2024
1Antipsychotic Agents (Antipsychotics)IBA
02/2024
1Dihydrotachysterol (AT 10)IBA
04/2009
1Potassium Channels (Potassium Channel)IBA
04/2009
1HLA-B57 antigenIBA
03/2004
1melanocortin 5 receptorIBA
04/2001

Therapy/Procedure

1Corneal Cross-Linking
11/2023
1Cesarean Section (Caesarean Section)
01/2023
1Subcutaneous Injections
04/2009